Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-25 @ 8:25 PM
Study NCT ID:
NCT04239469
Status:
UNKNOWN
Last Update Posted:
2020-01-27
First Post:
2020-01-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
Sponsor:
Knop Laboratorios
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-06-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-05
First Submit QC Date:
None
Study First Post Date:
2020-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-22
Last Update Post Date:
2020-01-27
Last Update Post Date Type:
ACTUAL